Manifesto for a European research network into Problematic Usage of the Internet
Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal
Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network
Although physical isolation and lockdown represent essential public health measures for containing the spread of the COVID-19 pandemic, they are a serious threat for mental health and well-being of the general population.
Is cyberchondria a new transdiagnostic digital compulsive syndrome? A systematic review of the evidence.
Romantic Attachment in Patients with Mood and Anxiety Disorders
The findings indicate that patients with different psychiatric disorders would be characterized by higher scores on both the ECR anxiety and the avoidance scales, as well as by the preoccupied style of attachment.
Cytokine Polymorphisms in the Pathophysiology of Mood Disorders
The data support the existence of a genetic profile related to pro-inflammatory cytokines in patients affected by mood disorders and suggest the presence of different pathogenetic mechanisms involved in the susceptibility of phenotypically different mood disorders.
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
- B. Dell’Osso, G. Nestadt, A. Allen, E. Hollander
- PsychologyJournal of Clinical Psychiatry
- 15 April 2006
The SNRIs may represent a valid alternative to the SSRIs, particularly in specific cases, and might be preferred for patients with certain types of treatment-resistant OCD or those with particular comorbid conditions.
How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive…
The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial
The “COVID-IT-mental health trial” is a no-profit, not-funded, national, multicentric, cross-sectional population-based trial which has the following aims: to evaluate the impact of COVID-19 pandemic and its containment measures on mental health of the Italian population and to identify the main areas to be targeted by supportive long-term interventions for the different categories of people exposed to the pandemic.
Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
Augmentative low-frequency rTMS of the right DLPFC combined with brain navigation was effective and well tolerated in a small sample of drug-resistant bipolar depressive patients, even though the lack of a sham controlled group limits confidence in the results.